Human Molecular Genetics, Vol 7, 53-62, Copyright © 1998 by Oxford University Press
AG Bijvoet, EH van de Kamp, MA Kroos, JH Ding, BZ Yang, P Visser, CE Bakker, MP Verbeet, BA Oostra, AJ Reuser and AT van der Ploeg
Glycogen storage disease type II (GSDII; Pompe disease), caused by
inherited deficiency of acid alpha-glucosidase, is a lysosomal disorder
affecting heart and skeletal muscles. A mouse model of this disease was
obtained by targeted disruption of the murine acid alpha-glucosidase gene
(Gaa) in embryonic stem cells. Homozygous knockout mice (Gaa -/-) lack Gaa
mRNA and have a virtually complete acid alpha-glucosidase deficiency.
Glycogen-containing lysosomes are detected soon after birth in liver, heart
and skeletal muscle cells. By 13 weeks of age, large focal deposits of
glycogen have formed. Vacuolar spaces stain positive for acid phosphatase
as a sign of lysosomal pathology. Both male and female knockout mice are
fertile and can be intercrossed to produce progeny. The first born knockout
mice are at present 9 months old. Overt clinical symptoms are still absent,
but the heart is typically enlarged and the electrocardiogram is abnormal.
The mouse model will help greatly to understand the pathogenic mechanism of
GSDII and is a valuable instrument to explore the efficacy of different
therapeutic interventions.
ARTICLES
Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease
Department of Clinical Genetics, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. H. Hubner, P. L. Leopold, M. Kiuru, B. P. De, A. Krause, and R. G. Crystal Dysfunctional Glycogen Storage in a Mouse Model of {alpha}1-Antitrypsin Deficiency Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 239 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Douillard-Guilloux, N. Raben, S. Takikita, L. Batista, C. Caillaud, and E. Richard Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II Hum. Mol. Genet., December 15, 2008; 17(24): 3876 - 3886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Moreland, X. Jin, X. K. Zhang, R. W. Decker, K. L. Albee, K. L. Lee, R. D. Cauthron, K. Brewer, T. Edmunds, and W. M. Canfield Lysosomal Acid {alpha}-Glucosidase Consists of Four Different Peptides Processed from a Single Chain Precursor J. Biol. Chem., February 25, 2005; 280(8): 6780 - 6791. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lynch, J. Johnson, C. Vaccaro, and B. L. Thurberg High-resolution Light Microscopy (HRLM) and Digital Analysis of Pompe Disease Pathology J. Histochem. Cytochem., January 1, 2005; 53(1): 63 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. T. Schuldt, T. J. Hampton, V. Chu, C. A. Vogler, N. Galvin, M. D. Lessard, and J. E. Barker Electrocardiographic and other cardiac anomalies in {beta}-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation PNAS, January 13, 2004; 101(2): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Johnson, S. Mahmood, and M. S. Patel Intermediary Metabolism and Energetics during Murine Early Embryogenesis J. Biol. Chem., August 22, 2003; 278(34): 31457 - 31460. [Full Text] [PDF] |
||||
![]() |
M. Arad, I. P. Moskowitz, V. V. Patel, F. Ahmad, A. R. Perez-Atayde, D. B. Sawyer, M. Walter, G. H. Li, P. G. Burgon, C. T. Maguire, et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy Circulation, June 10, 2003; 107(22): 2850 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cherqui, C. Sevin, G. Hamard, V. Kalatzis, M. Sich, M. O. Pequignot, K. Gogat, M. Abitbol, M. Broyer, M.-C. Gubler, et al. Intralysosomal Cystine Accumulation in Mice Lacking Cystinosin, the Protein Defective in Cystinosis Mol. Cell. Biol., November 1, 2002; 22(21): 7622 - 7632. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Umapathysivam, J. J. Hopwood, and P. J. Meikle Determination of Acid {alpha}-Glucosidase Activity in Blood Spots as a Diagnostic Test for Pompe Disease Clin. Chem., August 1, 2001; 47(8): 1378 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. J. KAMPHOVEN, R. STUBENITSKY, A. J. J. REUSER, A. T. VAN DER PLOEG, P. D. VERDOUW, and D. J. DUNCKER Cardiac remodeling and contractile function in acid {{alpha}}-glucosidase knockout mice Physiol Genomics, April 27, 2001; 5(4): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Umapathysivam, A. M. Whittle, E. Ranieri, C. Bindloss, E. M. Ravenscroft, O. P. van Diggelen, J. J. Hopwood, and P. J. Meikle Determination of Acid {alpha}-Glucosidase Protein: Evaluation as a Screening Marker for Pompe Disease and Other Lysosomal Storage Disorders Clin. Chem., September 1, 2000; 46(9): 1318 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Belke, T. S. Larsen, G. D. Lopaschuk, and D. L. Severson Glucose and fatty acid metabolism in the isolated working mouse heart Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1210 - R1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amalfitano, A. J. McVie-Wylie, H. Hu, T. L. Dawson, N. Raben, P. Plotz, and Y. T. Chen Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha -glucosidase PNAS, August 3, 1999; 96(16): 8861 - 8866. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ponce, D. P. Witte, R. Hirschhorn, M. L. Huie, and G. A. Grabowski Murine Acid {alpha}-Glucosidase : Cell-Specific mRNA Differential Expression during Developmentand Maturation Am. J. Pathol., April 1, 1999; 154(4): 1089 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Raben, K. Nagaraju, E. Lee, P. Kessler, B. Byrne, L. Lee, M. LaMarca, C. King, J. Ward, B. Sauer, et al. Targeted Disruption of the Acid alpha -Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II J. Biol. Chem., July 24, 1998; 273(30): 19086 - 19092. [Abstract] [Full Text] [PDF] |
||||










